Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.1M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
58.7M
-
Shares change
-
+911K
-
Total reported value, excl. options
-
$700M
-
Value change
-
+$12.5M
-
Put/Call ratio
-
0.16
-
Number of buys
-
64
-
Number of sells
-
-59
-
Price
-
$11.94
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) as of Q3 2024
152 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.7M shares
of 67.1M outstanding shares and own 87.38% of the company stock.
Largest 10 shareholders include BVF INC/IL (9.14M shares), Paradigm Biocapital Advisors LP (5.5M shares), Deep Track Capital, LP (4M shares), BlackRock, Inc. (3.85M shares), Point72 Asset Management, L.P. (3.69M shares), Logos Global Management LP (3.21M shares), MPM BIOIMPACT LLC (2.68M shares), VANGUARD GROUP INC (2.53M shares), STATE STREET CORP (1.97M shares), and Pictet Asset Management Holding SA (1.67M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.